Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Hansson

Showing results (161-170 of 199) with videos related to

Pageof 20
Sort By:
Journal of the National Cancer Institute|June 20, 2002
Geographical variation in the penetrance of CDKN2A mutations for melanomaD Timothy Bishop, Florence Demenais, Alisa M Goldstein, et al.
BMC Cancer|December 8, 2020
TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant MelanomaYlva Naeser, Hildur Helgadottir, Yvonne Brandberg, et al.
BMJ Open|February 22, 2023
Inhaled ciclesonide in adults hospitalised with COVID-19: a randomised controlled open-label trial (HALT COVID-19)Daniel Brodin, Per Tornhammar, Peter Ueda, et al.
European Journal of Dermatology : EJD|January 31, 2019
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE studyJohan Hansson, Karen Bartley, Thomas Karagiannis, et al.
Clinical Epigenetics|August 5, 2018
Increased CD4<sup>+</sup> T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patientsEmma Ahlén Bergman, Ciputra Adijaya Hartana, Markus Johansson, et al.
The Journal of Investigative Dermatology|June 18, 2013
Somatic BRAF and NRAS mutations in familial melanomas with known germline CDKN2A status: a GenoMEL studyAbdlsattar Zebary, Katarina Omholt, Remco van Doorn, et al.
American Journal of Human Genetics|July 7, 2010
IRF4 variants have age-specific effects on nevus count and predispose to melanomaDavid L Duffy, Mark M Iles, Dan Glass, et al.
BMC Medical Genomics|December 5, 2013
Integrated molecular portrait of non-small cell lung cancersVladimir Lazar, Chen Suo, Cedric Orear, et al.
Cancer Research|October 3, 2007
FBXW7/hCDC4 is a general tumor suppressor in human cancerShahab Akhoondi, Dahui Sun, Natalie von der Lehr, et al.
American Journal of Human Genetics|July 5, 2003
Localization of a novel melanoma susceptibility locus to 1p22Elizabeth Gillanders, Suh-Hang Hank Juo, Elizabeth A Holland, et al.
Pageof 20

Showing results (161-170 of 199) with videos related to

Sort By:
Pageof 20
Journal of the National Cancer Institute|June 20, 2002
Geographical variation in the penetrance of CDKN2A mutations for melanomaD Timothy Bishop, Florence Demenais, Alisa M Goldstein, et al.
BMC Cancer|December 8, 2020
TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant MelanomaYlva Naeser, Hildur Helgadottir, Yvonne Brandberg, et al.
BMJ Open|February 22, 2023
Inhaled ciclesonide in adults hospitalised with COVID-19: a randomised controlled open-label trial (HALT COVID-19)Daniel Brodin, Per Tornhammar, Peter Ueda, et al.
European Journal of Dermatology : EJD|January 31, 2019
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE studyJohan Hansson, Karen Bartley, Thomas Karagiannis, et al.
Clinical Epigenetics|August 5, 2018
Increased CD4<sup>+</sup> T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patientsEmma Ahlén Bergman, Ciputra Adijaya Hartana, Markus Johansson, et al.
The Journal of Investigative Dermatology|June 18, 2013
Somatic BRAF and NRAS mutations in familial melanomas with known germline CDKN2A status: a GenoMEL studyAbdlsattar Zebary, Katarina Omholt, Remco van Doorn, et al.
American Journal of Human Genetics|July 7, 2010
IRF4 variants have age-specific effects on nevus count and predispose to melanomaDavid L Duffy, Mark M Iles, Dan Glass, et al.
BMC Medical Genomics|December 5, 2013
Integrated molecular portrait of non-small cell lung cancersVladimir Lazar, Chen Suo, Cedric Orear, et al.
Cancer Research|October 3, 2007
FBXW7/hCDC4 is a general tumor suppressor in human cancerShahab Akhoondi, Dahui Sun, Natalie von der Lehr, et al.
American Journal of Human Genetics|July 5, 2003
Localization of a novel melanoma susceptibility locus to 1p22Elizabeth Gillanders, Suh-Hang Hank Juo, Elizabeth A Holland, et al.
Pageof 20